Pearl IRB is pleased to launch it’s whitepaper entitled “Trends and Insights in IRB Warning Letters.” Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to...
August 2, 2010 Pearl IRB releases news about their role in fostering clinical trials in Indiana and beyond. Check out the full release, read a quote provided by Kristin Jones, President of Indiana Health Industry Forum and more. Read more.
Ethics of Safety Studies for Marketed Drugs Even the Average Joe couldn’t have missed the discussions regarding the safety risks of Avandia. FDA is again in a tough spot and looking for answers. Traditionally, Industry was not to make safety claims about drugs, just...
Operations – Regulatory – Contracts – Budgets This year, MAGI is expecting a large increase in attendees…up 50% over last year to a record 600 attendees. This conference is for study sponsors, research sites, or CROs in a corporate, academic...
Staying in compliance with procedures and Regulators…It shouldn’t be that hard. You write up the way you will run your business based on regulations and industry practice and you run your business that way. What’s the problem? Creating the system is mundane, but...
